Mehran Makvandi
- Oncology top 5%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 5%
- Organic Chemistry top 10%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Robert H. MachKuiying XuDaniel A. PrymaChenbo ZengSean W. ReillyCatherine HouChi-Chang WengHarrison D. Winters
- Topics
- PARP inhibition in cancer therapy (24 papers)DNA Repair Mechanisms (11 papers)Neuroblastoma Research and Treatments (9 papers)
- Journals
- Journal of the American Chemical SocietyJournal of Clinical InvestigationJournal of Clinical Oncology
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Mehran Makvandi
47 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Oncology 555
- Molecular Biology 496
- Radiology, Nuclear Medicine and Imaging 398
- Organic Chemistry 235
- Pulmonary and Respiratory Medicine 204
Countries citing papers authored by Mehran Makvandi
This map shows the geographic impact of Mehran Makvandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehran Makvandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehran Makvandi more than expected).
Fields of papers citing papers by Mehran Makvandi
This network shows the impact of papers produced by Mehran Makvandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehran Makvandi. The network helps show where Mehran Makvandi may publish in the future.
Co-authorship network of co-authors of Mehran Makvandi
This figure shows the co-authorship network connecting the top 25 collaborators of Mehran Makvandi. A scholar is included among the top collaborators of Mehran Makvandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mehran Makvandi. Mehran Makvandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 14 | |
| 3 | 5 | |
| 4 | 14 | |
| 5 | 24 | |
| 6 | 21 | |
| 7 | 39 | |
| 8 | 25 | |
| 9 | 23 | |
| 10 | 7 | |
| 11 | 29 | |
| 12 | 97 | |
| 13 | 72 | |
| 14 | 18 | |
| 15 | 22 | |
| 16 | 80 | |
| 17 | 54 | |
| 18 | 30 | |
| 19 | 15 | |
| 20 | 18 |
About Mehran Makvandi
Mehran Makvandi is a scholar working on Oncology, Neurology and Radiology, Nuclear Medicine and Imaging, having authored 47 papers that have together received 1.3k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (24 papers), DNA Repair Mechanisms (11 papers) and Neuroblastoma Research and Treatments (9 papers). The work is most often cited by research in Oncology (555 citations), Radiology, Nuclear Medicine and Imaging (398 citations) and Structural Biology (19 citations). Mehran Makvandi has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Robert H. Mach, Kuiying Xu, Daniel A. Pryma, Chenbo Zeng, Sean W. Reilly, Catherine Hou, Chi-Chang Weng, Harrison D. Winters, Yongxiang Zheng and Roshan K. Dhungana. Their work appears in journals such as Journal of the American Chemical Society, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.